首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse CD3 Antibody
产品名称:
PerCP/Cyanine5.5 anti-mouse CD3 Antibody
产品类别:
抗体
产品编号:
100217
产品应用:
100217
[价格]
规格 价格 库存
25µg ¥ 1416 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  2. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  2. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  3. Chen Y, et al. 2020. Virol Sin. . PubMed
  4. Abraham A, et al. 2019. J Clin Invest. 130:2685. PubMed
  5. Li SX, et al. 2019. PLoS Pathog. 15:e1007611. PubMed
  6. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  7. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  8. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  9. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  10. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  11. Ye Y, et al. 2022. Nat Commun. 13:6458. PubMed
  12. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  13. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  14. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  15. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  16. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  17. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  18. Molofsky A, et al. 2013. J Exp Med. 210:535. PubMed
  19. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  20. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  21. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  22. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  23. Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
  24. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  25. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  26. Yang F, et al. 2020. Cancer Res. 80:3677. PubMed
  27. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  28. Jin Q, et al. 2022. Drug Des Devel Ther. 16:3297. PubMed
  29. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  30. Zirngibl F, et al. 2021. J Immunother Cancer. 9:. PubMed
  31. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  32. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  33. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  34. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  35. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  36. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  37. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  38. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  39. Soutto M, et al. 2017. J Cancer. 8:2424. PubMed
  40. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  41. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  42. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  43. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  44. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  45. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  46. Kennedy EM, et al. 2022. Nat Commun. 13:5907. PubMed
  47. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  48. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  49. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  50. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  51. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  52. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  53. Tian Y, et al. 2016. J Immunol. 197: 1308 - 1321. PubMed
  54. Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
  55. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  56. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  57. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  58. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  59. Agarwal P, et al. 2019. Cell Stem Cell. 24:769. PubMed
  60. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  61. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  62. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  63. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  64. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  65. Shehata L, et al. 2019. Cell Rep. 28:3300. PubMed
  66. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  67. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  68. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  69. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  70. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  71. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  72. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  73. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  74. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  75. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  76. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  77. Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
  78. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  79. T?htinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  80. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  81. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  82. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  83. Agarwal P, et al. 2021. Cell Reports. 36(2):109386. PubMed
  84. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  85. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  86. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  87. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  88. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  89. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  90. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
RRID
AB_1595597 (BioLegend Cat. No. 100217) AB_1595492 (BioLegend Cat. No. 100218)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线